Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
eli lilly
life sciences
national blog main
boston blog main
boston top stories
clinical trials
fda
indiana blog main
indiana top stories
national top stories
san francisco blog main
san francisco top stories
amgen
avapritinib
blueprint medicines
boston
calcitonin gene-related peptide
chronic migraine
episodic migraine
genentech
medullary thyroid cancer
non-small cell lung cancer
novartis
pralsetinib
roche
selpercatinib
teva pharmaceutical
thyroid cancer
alder biopharmaceuticals
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
capmatinib
cstone pharmaceuticals
david rind
deals
detroit blog main
detroit top stories
What
approval
4
×
drug
fda
medicines
4
×
blueprint
cancer
class
developed
migraine
new
pain
ret
starts
won
address
amgen
announced
approved
approves
candidate
candidates
carries
certain
currently
decision
designed
eli
genetic
gets
head
headache
late
latest
lilly
marketing
marks
muscle
nod
pact
pass
Language
unset
Current search:
approval
×
medicines
×
biotech
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
